Literature DB >> 31092515

Pyoderma gangrenosum - a guide to diagnosis and management .

Christina George1, Florence Deroide2, Malcolm Rustin2.   

Abstract

Pyoderma gangrenosum (PG) is a reactive non-infectious inflammatory dermatosis falling under the spectrum of the neutrophilic dermatoses. There are several subtypes, with 'classical PG' as the most common form in approximately 85% cases. This presents as an extremely painful erythematous lesion which rapidly progresses to a blistered or necrotic ulcer. There is often a ragged undermined edge with a violaceous/erythematous border. The lower legs are most frequently affected although PG can present at any body site. Other subtypes include bullous, vegetative, pustular, peristomal and superficial granulomatous variants. The differential diagnosis includes all other causes of cutaneous ulceration as there are no definitive laboratory or histopathological criteria for PG. Underlying systemic conditions are found in up to 50% of cases and thus clinicians should investigate thoroughly for such conditions once a diagnosis of PG has been made. Treatment of PG remains largely anecdotal, with no national or international guidelines, and is selected according to severity and rate of progression. Despite being a well-recognised condition, there is often a failure to make an early diagnosis of PG. This diagnosis should be actively considered when assessing ulcers, as prompt treatment may avoid the complications of prolonged systemic therapy, delayed wound healing and scarring. © Royal College of Physicians 2019. All rights reserved.

Entities:  

Keywords:  Dermatology; neutrophilic dermatosis; pyoderma gangrenosum; ulcer

Year:  2019        PMID: 31092515      PMCID: PMC6542232          DOI: 10.7861/clinmedicine.19-3-224

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  41 in total

1.  Topical treatment of pyoderma gangraenosum.

Authors:  Joerg Wenzel; Rainer Gerdsen; Wolfgang Phillipp-Dormston; Thomas Bieber; Manfred Uerlich
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

2.  Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease.

Authors:  Xian-rui Wu; Saurabh Mukewar; Ravi P Kiran; Feza H Remzi; Jeffery Hammel; Bo Shen
Journal:  J Crohns Colitis       Date:  2012-09-05       Impact factor: 9.071

3.  Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.

Authors:  Markus Braun-Falco; Oleksandr Kovnerystyy; Peter Lohse; Thomas Ruzicka
Journal:  J Am Acad Dermatol       Date:  2011-07-13       Impact factor: 11.527

Review 4.  Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.

Authors:  M L Bennett; J M Jackson; J L Jorizzo; A B Fleischer; W L White; J P Callen
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

Review 5.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

6.  Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.

Authors:  Cynthia M Magro; Bahram Kiani; Jingwei Li; A Neil Crowson
Journal:  J Cutan Pathol       Date:  2007-07       Impact factor: 1.587

7.  Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment.

Authors:  Alexandra Geusau; Nadine Mothes-Luksch; Hesam Nahavandi; Winfried F Pickl; Carol A Wise; Zahra Pourpak; Elisabeth Ponweiser; Leopold Eckhart; Raute Sunder-Plassmann
Journal:  JAMA Dermatol       Date:  2013-02       Impact factor: 10.282

8.  Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series.

Authors:  Carlos A Charles; Argentina Leon; Meggan R Banta; Robert S Kirsner
Journal:  Int J Dermatol       Date:  2007-10       Impact factor: 2.736

9.  Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene.

Authors:  Angelo V Marzano; Valentina Trevisan; Marco Gattorno; Isabella Ceccherini; Clara De Simone; Carlo Crosti
Journal:  JAMA Dermatol       Date:  2013-06       Impact factor: 10.282

10.  T-cell receptor repertoire in pyoderma gangrenosum: evidence for clonal expansions and trafficking.

Authors:  T N Brooklyn; A M Williams; M G S Dunnill; C S Probert
Journal:  Br J Dermatol       Date:  2007-11       Impact factor: 9.302

View more
  23 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Pyoderma gangrenosum confused with congenital preauricular fistula infection: A case report.

Authors:  Yang Zhao; Rou-Yu Fang; Guo-Dong Feng; Ting-Ting Cui; Zhi-Qiang Gao
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

3.  Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome.

Authors:  Orlando Zagaria; Angelo Ruggiero; Gabriella Fabbrocini; Lucia Gallo; Marco Romanelli; Claudio Marasca
Journal:  Int Wound J       Date:  2020-05-22       Impact factor: 3.315

Review 4.  Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.

Authors:  Louis-Pierre Girard; Cinnie Yentia Soekojo; Melissa Ooi; Wee Joo Chng; Sanjay de Mel
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

5.  Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.

Authors:  Alina Nazir; Ali Zafar
Journal:  Cureus       Date:  2022-05-21

6.  A Case of Recurrent Idiopathic Pyoderma Gangrenosum.

Authors:  Filipa David; Rafaela Lopes Freitas; Rute Brás-Cruz; Joana Rocha; Cristina Rosário
Journal:  Cureus       Date:  2022-05-18

7.  COVID-19 Vaccine: A Possible Trigger for Pyoderma Gangrenosum.

Authors:  Ahmed B Mohd; Omar B Mohd; Reem A Ghannam; Mohammad H Al-Thnaibat
Journal:  Cureus       Date:  2022-05-24

8.  The great imitator with no diagnostic test: pyoderma gangrenosum.

Authors:  Teresa Alonso-León; Heidi H Hernández-Ramírez; Veronica Fonte-Avalos; Sonia Toussaint-Caire; María E Vega-Memije; Adriana Lozano-Platonoff
Journal:  Int Wound J       Date:  2020-08-11       Impact factor: 3.315

Review 9.  Pyoderma Gangrenosum in a Splenectomy Incision in a Patient with Haemolytic Anaemia due to Hereditary Spherocytosis: a Case Report and Literature Review.

Authors:  Piotr K Krajewski; Iwona Chlebicka; Jacek C Szepietowski; Joanna Maj
Journal:  Acta Derm Venereol       Date:  2021-11-24       Impact factor: 3.875

10.  Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis.

Authors:  Rotem Semo Oz; Oluwakemi Onajin; Liora Harel; Rotem Tal; Tomas Dallos; Adena Rosenblatt; Lukas Plank; Linda Wagner-Weiner
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-05       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.